If TKM-Ebola does seem to work, the team wants to go straight to a bigger phase III clinical trial. It’s essential that we push forward with clinical trials while we still have a realistic chance of getting answers about which, if any, of the candidate treatments can save lives in this, and in future outbreaks,” said principal investigator Peter Horby in a statement released today by the Wellcome Trust, a charity that is funding the trial.